Skinvisible, Inc. (SKVI)
OTCMKTS: SKVI · Delayed Price · USD
+0.039 (62.64%)
May 10, 2024, 3:58 PM EDT - Market closed

Skinvisible Statistics

Total Valuation

Skinvisible has a market cap or net worth of $458,524. The enterprise value is $6.64 million.

Market Cap 458,524
Enterprise Value 6.64M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Skinvisible has 4.54 million shares outstanding.

Shares Outstanding 4.54M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 4.20%
Owned by Institutions (%) n/a
Float 4.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 22.93
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 331.79
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio 0.01
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.45

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -754.72%
Return on Capital (ROIC) n/a
Revenue Per Employee $10,000
Profits Per Employee -$578,878
Employee Count 2
Asset Turnover 0.12
Inventory Turnover n/a


In the past 12 months, Skinvisible has paid $335,287 in taxes.

Income Tax 335,287
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.54% in the last 52 weeks. The beta is -0.49, so Skinvisible's price volatility has been lower than the market average.

Beta (1Y) -0.49
52-Week Price Change +2.54%
50-Day Moving Average 0.08
200-Day Moving Average 0.08
Relative Strength Index (RSI) 62.95
Average Volume (30 Days) 1,006

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Skinvisible had revenue of $20,000 and -$1.16 million in losses. Loss per share was -$0.26.

Revenue 20,000
Gross Profit 1,178
Operating Income -485,653
Pretax Income -1.16M
Net Income -1.16M
EBITDA -466,823
EBIT -485,645
Loss Per Share -$0.26
Full Income Statement

Balance Sheet

The company has $8,097 in cash and $6.19 million in debt, giving a net cash position of -$6.18 million or -$1.36 per share.

Cash & Cash Equivalents 8,097
Total Debt 6.19M
Net Cash -6.18M
Net Cash Per Share -$1.36
Equity / Book Value -9.31M
Book Value Per Share -2.05
Working Capital -4.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$37,733 and capital expenditures $525, giving a free cash flow of -$37,208.

Operating Cash Flow -37,733
Capital Expenditures 525
Free Cash Flow -37,208
FCF Per Share -$0.01
Full Cash Flow Statement


Gross margin is 5.89%, with operating and profit margins of -2,428.27% and -5,788.78%.

Gross Margin 5.89%
Operating Margin -2,428.27%
Pretax Margin -5,788.78%
Profit Margin -5,788.78%
EBITDA Margin -2,334.12%
EBIT Margin -2,428.23%
FCF Margin -186.04%

Dividends & Yields

Skinvisible does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -252.50%
FCF Yield -8.11%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on January 4, 2019. It was a reverse split with a ratio of 1:50.

Last Split Date Jan 4, 2019
Split Type Reverse
Split Ratio 1:50


Skinvisible has an Altman Z-Score of -404.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -404.12
Piotroski F-Score 2